Libya has achieved something truly remarkable: the World Health Organization (WHO) has officially declared the elimination of trachoma as a public health problem in the country. But here's where it gets even more impressive: this milestone was reached despite years of political turmoil and humanitarian crises that strained healthcare services, displaced communities, and put immense pressure on water and sanitation systems. So, how did they do it? And what does this mean for the rest of the world?
On February 18, the WHO announced that Libya has become the 28th country globally—and the eighth in the eastern Mediterranean region—to eliminate trachoma, a painful and potentially blinding bacterial infection. This achievement is a testament to the resilience of Libya's healthcare system and the dedication of its partners, both local and international. And this is the part most people miss: the country's success wasn't just about treating the disease; it was about building a comprehensive program that integrated surveillance, expanded surgical services, and strengthened the capacity of health workers.
Trachoma, caused by the bacterium Chlamydia trachomatis, spreads through contact with eye discharge from infected individuals, often via hands, clothing, or flies. Repeated infections can lead to a condition called trichiasis, where the eyelashes turn inward and scrape the eye, causing excruciating pain and, if untreated, blindness. In Libya, trachoma has been documented for over a century, with high infection rates in the southern regions during the 20th century. Control efforts began in the 1970s and 1980s, but it wasn’t until recently that the country saw a significant decline in transmission.
Surveys conducted in 2022 across six southern districts revealed that the prevalence of active trachoma and trichiasis had fallen below the WHO’s elimination thresholds, with the exception of trichiasis in Wadi Al Hayaa/Ghat. In response, a surgical campaign was launched to treat the remaining cases. A follow-up survey in 2025 confirmed that even trichiasis had dropped below the threshold, solidifying Libya’s success.
Here’s the controversial part: While Libya’s achievement is undoubtedly a triumph, it raises questions about why other countries facing similar challenges haven’t made the same progress. Is it a matter of resources, political will, or something else entirely? And what can we learn from Libya’s approach to apply to other neglected tropical diseases?
Libya’s story is not just about eliminating a disease; it’s about hope, resilience, and the power of collaboration. But it also challenges us to think critically about global health inequities and what it truly takes to overcome them. What do you think? Is Libya’s success a blueprint for others, or are there unique factors at play here? Let’s discuss in the comments!
